- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Jazz
Recent news which mentions Jazz
7 F-Rated Stocks to Sell Before We Reach Christmas
November 10, 2021
From InvestorPlace
Jazz Pharmaceuticals PLC (JAZZ) Q3 2021 Earnings Call Transcript
November 10, 2021
Tickers
JAZZ
From Motley Fool
Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance
November 09, 2021
Tickers
JAZZ
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
From Benzinga
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
November 01, 2021
From Benzinga
2 Top Growth Stocks to Buy Heading Into November
October 30, 2021
From Motley Fool
7 Top Stocks to Buy On Any Dip If You Get the Chance in Q4
October 27, 2021
From InvestorPlace
From Benzinga
Bob Holz to release new album featuring John Mclaughlin, Jean Luc Ponty, Darryl Jones and Randy Brecker
October 26, 2021
Tickers
JAZZ
From PRLog
3 Dirt-Cheap Stocks Wall Street Thinks Will Soar 43% to 80%
October 22, 2021
From Motley Fool
Leading the Charge to Develop the First Orexin-Targeted Therapy to Address Narcolepsy at its Root Cause
October 20, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
From Benzinga
Needham Initiates Coverage With Buy For This Narcolepsy Player
September 23, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
September Sell-Off: 3 Dirt Cheap Growth Stocks to Buy
September 22, 2021
From Motley Fool
A Tribe For Jazz to Receive Resolution from the City of Columbus Celebrating Film Featuring Jazz Musician Jon Irabagon and Acknowledging Community Outreach
September 20, 2021
Tickers
JAZZ
From PRUnderground
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025
September 08, 2021
Tickers
JAZZ
From Benzinga
3 Hypergrowth Stocks Expected to Increase Sales 1,185% to 12,629% by 2023
September 03, 2021
From Motley Fool
3 Biotech Stocks That Are Too Cheap to Ignore
September 02, 2021
From Motley Fool
From Benzinga
Canada Approves Jazz Pharma's Excessive Daytime Sleepiness Med
August 31, 2021
Tickers
JAZZ
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.